Latest news
Oramed Pharmaceuticals (NASDAQ:ORMP) Releases Quarterly Earnings Results - MarketBeatMarketBeat · Mon, 10 Aug 2026 22:28:04 GMTOramed Pharmaceuticals Inc expected to post earnings of 43 cents a share - Earnings Preview - TradingViewTradingView · Mon, 10 Aug 2026 21:58:04 GMTOramed Pharmaceuticals (NASDAQ: ORMP) pivots to investment model with $116M profit - Stock TitanStock Titan · Mon, 10 Aug 2026 21:30:27 GMTOramed Pharmaceuticals Inc (ORMP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 19:37:21 GMTOramed Pharmaceuticals (ORMP) Projected to Release Quarterly Earnings on Thursday - MarketBeatMarketBeat · Thu, 06 Aug 2026 13:36:41 GMTORMP Q2'26 Earnings: revenue estimate is 0 USD - TradingViewTradingView · Wed, 05 Aug 2026 11:00:21 GMTOramed Pharmaceuticals announces annual shareholder meeting - BitgetBitget · Tue, 04 Aug 2026 07:54:57 GMTORAMED PHARMACEUTICALS INC. SEC Filing (Aug 3, 2026) - Stock TitanStock Titan · Mon, 03 Aug 2026 20:24:11 GMT